Kazuhide Oshiden - Concepedia

Author

Kazuhide Oshiden

Otsuka (Japan)

Also Known As

K Oshiden, K. Oshiden, Kazuhide Oshiden

Publications

649

Citations

H-Index

Concepts

All Affiliations

Otsuka (Japan)Kyoto Prefectural University of Medicine Nippon Medical School

About

Kazuhide Oshiden is an author at Otsuka (Japan) specializing in medicine, ophthalmology, and ocular pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	579
2	Immunology	1	1	20
3	Nephrology	1	1	20
4	Pharmacology	1	1	140
5	Acute Kidney Injury	1	1	20

Kazuhide Oshiden

Publications

642

Citations

H-Index

Page 1

	Year	Citations
Presence of epidermal growth factor in human tears. Yuichi Ohashi, M Motokura, Yoshihisa Kinoshita, PubMed Human EgfEpidermal Growth FactorHuman TearsOphthalmologyHuman Growth	1989	215
Rebamipide (OPC-12759) in the Treatment of Dry Eye: A Randomized, Double-Masked, Multicenter, Placebo-Controlled Phase II Study Shigeru Kinoshita, Saki Awamura, Kazuhide Oshiden, Ophthalmology Ocular DiseaseOphthalmologyDry EyePharmacologyEye Health	2012	140
A Randomized, Multicenter Phase 3 Study Comparing 2% Rebamipide (OPC-12759) with 0.1% Sodium Hyaluronate in the Treatment of Dry Eye Shigeru Kinoshita, Kazuhide Oshiden, Saki Awamura, Ophthalmology Ocular DiseaseDry EyeOphthalmologyStudy Comparing 2Ocular Tissue	2013	137
A Multicenter, Open-Label, 52-Week Study of 2% Rebamipide (OPC-12759) Ophthalmic Suspension in Patients With Dry Eye Shigeru Kinoshita, Saki Awamura, Norihiro Nakamichi, American Journal of Ophthalmology Ophthalmic SuspensionOcular DiseaseDry EyeOphthalmology52-Week Study	2013	67
Phase 2, randomized, double‐blind, placebo‐controlled, 4‐week study to evaluate the safety and efficacy of OPA‐ 15406 (difamilast), a new topical selective phosphodiesterase type‐4 inhibitor, in Japanese pediatric patients aged 2–14 years with atopic dermatitis Hidehisa Saeki, Naoko Baba, Kazuhide Oshiden, The Journal of Dermatology	2019	38
Efficacy and safety of topical <scp>OPA</scp>‐15406, a new phosphodiesterase 4 inhibitor, in Japanese patients with atopic dermatitis for 8 weeks: A phase 2, randomized, double‐blind, placebo‐controlled study Hidehisa Saeki, Makoto Kawashima, Satoko Sugaya, The Journal of Dermatology	2019	25
Expression of epidermal growth factor and its receptor in rabbits with ischaemic acute renal failure Takayasu Taira, Akiyo Yoshimura, Katsumi Iizuka, Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin UrologyEpidermal Growth FactorRenal FunctionMedicineRenal Pathology	1996	20

Page 1